Mechanical Thrombectomy for Distal Medium Vessel Occlusions in Stroke: A Systematic Review and Meta-Analysis of RCTs

BackgroundMechanical thrombectomy (MT) is established as standard care for acute ischemic stroke (AIS) due to large vessel occlusion, but its role in distal medium vessel occlusions (DMVOs) remains uncertain. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of MT vs best medical management (BMM) in patients with DMVO-related AIS. MethodsA systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted through February 2025 to identify randomized controlled trials (RCTs) comparing MT to BMM in patients with DMVO. The primary outcome was functional independence at 90 days (modified Rankin Scale [mRS] 0-2). Secondary outcomes included excellent outcome (mRS 0-1), symptomatic intracerebral haemorrhage (sICH), all-cause mortality, and serious adverse events. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model and heterogeneity was assessed with the I2 statistic. ResultsThree RCTs involving 1,222 patients were included; 601 received MT and 623 received BMM. MT was not associated with improved functional independence at 90 days (OR, 0.81; 95% CI, 0.49-1.32). The risk of sICH was higher in the MT group (OR, 2.33; 95% CI, 1.31- 4.13), while mortality rates were similar (OR, 1.33; 95% CI, 0.90-1.98). In a subgroup of 466 patients with M2 occlusions, MT showed no significant benefit over BMM (OR, 0.93; 95% CI, 0.72-1.19). ConclusionsMT did not improve functional outcomes in patients with DMVO, including those with M2 occlusions, and was associated with a higher risk of sICH. Further trials are warranted to refine patient selection and procedural approaches in this population.